Asia-Pacific OTC Drugs Market Trends, Research Report, Growth, Opportunities, Forecast 2021-2027
The Asia-Pacific OTC drugs market is
anticipated to grow at a CAGR of 7.9% during the forecast period. The market
growth is attributed to the increasing trend of self-medication in the region
coupled with the increasing healthcare spending. Major economies covered in the
study of the Asia-Pacific OTC drugs industry report covers the analysis of
China, Japan, India, and Rest of Asia-Pacific. Among these, India is an
emerging region in the OTC drug landscape. Some of the major players in the OTC
drug industry in India include Cipla, Dabur, Emami, GlaxoSmithKline, Piramal,
and others.
A full report of Asia-Pacific OTC Drugs Market is
available at: https://www.omrglobal.com/industry-reports/asia-pacific-over-the-counter-otc-drugs-market
Moreover, the Indian government is
showing a keen interest in the growth of the Indian pharmaceutical sector among
the other countries. The initiatives by the government such as Pharma Vision
2020, National Biopharma Mission, and National Health Policy schemes are
driving the OTC drugs industry.
Some
of the key driving factors for the growth of the Indian OTC drugs industry are
as follows:
·
The rapid shift from Rx to OTC
·
Rise in the geriatric population.
·
The shift in consumer preference towards self-
medication.
·
Affordability of OTC drugs.
To
learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-over-the-counter-otc-drugs-market
Market
Coverage
·
Market numbers available for – 2018-2025
·
Base year- 2018
·
Forecast period- 2019-2025
·
Segment Covered-
o
By Product Type
o
By Distribution Channel
·
Countries Covered-
o
China
o
India
o
Japan
o
Rest of Asia-Pacific
·
Competitive Landscape- Cipla Ltd., The Piramal
Group, Novartis International AG, Dabur India Ltd., Johnson & Johnson
Services Inc., Teva Pharmaceuticals Industries. Ltd., and Takeda
Pharmaceuticals Co. Ltd.
Key
Questions Addressed by the Report
·
What is the current market size and growth rate
in the forecast period?
·
Which segment dominates the market in the base
year?
·
Which segment will project the fastest growth in
the market?
·
Impact on market growth due to the COVID-19
pandemic?
·
Who is the leader in the market?
·
How players are addressing challenges to sustain
growth?
·
Where is the investment opportunity?
For more customized data, request for report
customization @ https://www.omrglobal.com/report-customization/asia-pacific-over-the-counter-otc-drugs-market
Asia-Pacific OTC
Drugs Market Report Segment
By
Product Type
·
Analgesics & Pain Relievers
·
Cough, Cold & Flu Products
·
Vitamins & Mineral Supplements
·
Ophthalmic Products
·
Others
By
Distribution Channel
·
Retail & Supermarket
·
Online Platform
Company Profiles
·
Cipla Ltd.
·
Dabur India Limited
·
Emami Ltd.
·
GlaxoSmithKline Plc
·
Johnson &
Johnson Services Inc.
·
Novartis
International AG
·
Sun Pharmaceuticals
Ltd.
·
Takeda
Pharmaceutical Co. Ltd.
·
Teva Pharmaceutical
Industries Ltd.
·
The Piramal Group
·
The Procter &
Gamble Co.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no:
+91 780-304-0404
0 Comments